Pfizer buys Seagen for 43 billion

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Pfizer buys Seagen for 43 billion

posted on Mar 13, 2023 08:18PM

https://www.reuters.com/markets/deals/pfizer-buy-seagen-deal-valued-43-billion-2023-03-13/

Pfizer may want to leverage their cancer technology pipeline with an Epigenetics type of cancer combo drug or maybe another Pharma will want this technology

The potential is huge in a few years for any Pharma if the trials work out

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply